Clinical & Pharma

Global Prostate Cancer Burden Soars in Older Men
Clinical & Pharma Global Prostate Cancer Burden Soars in Older Men

A comprehensive analysis of global health data collected over three decades has delivered a sobering message about the escalating burden of prostate cancer among men aged 65 and older. This systematic review, which examined trends from 1990 through 2021, reveals a significant and continuous upward

How Do Swine Models Revolutionize Heart Care?
Clinical & Pharma How Do Swine Models Revolutionize Heart Care?

The journey of a life-saving medical device from an engineering concept to a clinical reality is fraught with challenges, particularly in the complex and dynamic environment of the human heart. For the millions suffering from heart failure, the promise of new transcatheter technologies offers a

Can New Drug Pacts End Patient Uncertainty?
Clinical & Pharma Can New Drug Pacts End Patient Uncertainty?

A new generation of pharmaceutical trade agreements is fundamentally reshaping the landscape of global healthcare, moving beyond abstract economic frameworks to become practical, patient-centric instruments designed to directly enhance the accessibility, affordability, and predictability of

How Do We Fight Outbreaks at the Genetic Level?
Clinical & Pharma How Do We Fight Outbreaks at the Genetic Level?

The silent, invisible spread of a novel virus across continents has become a defining challenge of our time, demanding a response that moves faster than the pathogen itself. In this high-stakes race, traditional epidemiological methods of contact tracing and symptom monitoring, while still

Why Is the CDC Sidelining Vaccines Experts Call Crucial?
Clinical & Pharma Why Is the CDC Sidelining Vaccines Experts Call Crucial?

With the federal government dramatically altering its guidance on childhood immunizations, the landscape of pediatric care has been thrown into uncertainty. We sat down with a leading expert in public health and infectious disease to unpack what this shift means for parents, doctors, and the health

What Does the NIH See in Bucks County Biotech?
Clinical & Pharma What Does the NIH See in Bucks County Biotech?

A high-stakes convergence of science and policy recently unfolded in Doylestown, Bucks County, as National Institutes of Health (NIH) Director Dr. Jay Bhattacharya accepted an invitation from Congressman Brian Fitzpatrick (PA-1) for a firsthand look at a thriving hub of biomedical innovation. The

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later